Publications by authors named "Amy L Carr"

Unlabelled: Sequencing of plasma microbial cell-free DNA (mcfDNA) has gained increased acceptance as a valuable adjunct to standard-of-care testing for diagnosis of infections throughout the body. Here, we report the analytical and clinical validation of a novel application of mcfDNA sequencing, the non-invasive detection of seven common antimicrobial resistance (AMR) genetic markers in 18 important pathogens. The AMR markers include SCC, , , , and .

View Article and Find Full Text PDF

Keeping abreast of the antimicrobial stewardship-related articles published each year is challenging. The Southeastern Research Group Endeavor identified antimicrobial stewardship-related, peer-reviewed literature that detailed an actionable intervention during 2022. The top 13 publications were selected using a modified Delphi technique.

View Article and Find Full Text PDF
Article Synopsis
  • This study focused on the incidence and treatment outcomes of disseminated Bartonella spp. infections, which are typically diagnosed using molecular tests like PCR due to limitations in traditional culture methods.
  • The research analyzed data from patients diagnosed with bartonellosis between 2014 and 2021, primarily identifying Bartonella henselae as the responsible pathogen, with doxycycline and rifampin being the most common treatment.
  • Results showed a notable 39% treatment failure rate, highlighting the importance of using various diagnostic tests and understanding treatment options for managing these infections.
View Article and Find Full Text PDF

Background: is an opportunistic, gram-negative bacillus with few therapeutic options due to a high level of intrinsic resistance. Trimethoprim/sulfamethoxazole (SXT) is recommended as the first-line treatment; however, minocycline (MIN) has been shown to have similar clinical outcomes in treating and addresses concern for increasing resistance to SXT.

Objective: The objective of this study is to evaluate the efficacy and safety outcomes of nonurinary, monomicrobial infections due to in hospitalized patients treated with MIN or SXT.

View Article and Find Full Text PDF

Background: Nasal colonization with methicillin-resistant (MRSA) can be detected using nasal swab polymerase chain reaction (PCR) assay and is associated with clinical MRSA infection. The MRSA nasal PCR has a rapid turnaround time and a negative predictive value for MRSA pneumonia of >98%; however, data are limited in critically ill patients.

Objective: The purpose of this study is to determine the impact of a pharmacist-driven algorithm, utilizing MRSA PCR nasal screening on duration of anti-MRSA therapy in patients admitted to the intensive care unit (ICU) with suspected pneumonia.

View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 uses the ACE2 enzyme to enter host cells, raising concerns about the use of RAAS inhibitors that increase ACE2 levels.
  • There is debate about whether to continue using ACE inhibitors and other RAAS blockers during the pandemic due to their complex role in inflammation and lung health.
  • Current observational data suggest that RAAS inhibitors do not harm patients with COVID-19, but further research is needed to evaluate new treatments and address the ongoing concerns about their effects on coronavirus infection rates.
View Article and Find Full Text PDF

Treatment options for Achromobacter xylosoxidans are limited. Eight cystic fibrosis patients with A. xylosoxidans were treated with 12 cefiderocol courses.

View Article and Find Full Text PDF

Significant clinical and financial consequences are associated with both inadequate and unnecessary exposure to broad-spectrum antibiotics. As such, antimicrobial stewardship programs seek objective, reliable, and cost-effective tests to identify patients at highest or lowest risk for drug-resistant organisms to guide empirical antimicrobial selection. Use of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA in lower respiratory tract infections has led to significant reductions in duration of vancomycin therapy.

View Article and Find Full Text PDF

The interferon-stimulated gene ISG15, a ubiquitin homolog, becomes conjugated to and regulates uterine proteins in response to conceptus-derived interferon-tau on d 18 of pregnancy. It was hypothesized here that cellular localization of ISG15 within endometrial cells might provide insight regarding function. Uteri were collected from cows (approximately 21-d estrous cycle) on d 17-21/0 of the estrous cycle and pregnancy and d 23, 45, and 50 of pregnancy.

View Article and Find Full Text PDF